Gina Kolata

6 days ago | nytimes.com | Rebecca Robbins |Gina Kolata

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. Encouraging clinical trial results announced on Thursday stand to open up a huge market for a convenient daily pill to treat obesity and diabetes. The experimental drug, developed by Eli Lilly and known as orforglipron, is a type of medication known as a GLP-1.

1 week ago | nytimes.com | Gina Kolata

Scientists developed a way to freeze a large mammal's kidney, which could ease organ shortages in the future. First, they had to see if their method would work in a pig. On the last day of March, surgeons at Massachusetts General Hospital began an operation that they hoped might lead to a permanent change in how kidneys are transplanted in people. That morning's patient was not a person. It was a pig, lying anesthetized on a table. The pig was missing one kidney and needed an implant.

2 weeks ago | nytimes.com | Gina Kolata

"The system is at the breaking point," said Dr. Benjamin S. Abella, chair of the department of emergency medicine at Mount Sinai's Icahn School of Medicine in New York. "The Pitt" follows emergency room doctors, nurses, medical students, janitors and staff hour by hour over a single day as they deal with all manner of medical issues, ranging from a child who drowned helping her little sister get out of a swimming pool to a patient with a spider in her ear.

2 weeks ago | nytimes.com | Gina Kolata

In retrospect, the program's fate was sealed in 2021 when its leaders applied for a renewal of their grant. It seemed pro forma. This was its eighth renewal. This time, though, an external committee of grant reviewers told the investigators their proposal's biggest weakness was a lack of diversity. The program needed to seek pediatricians who represented diverse ethnicities, economic backgrounds, states, types of research and pediatric specialties.

2 weeks ago | telegraphindia.com | Gina Kolata

The small study of nine patients announced recently by Beam Therapeutics of Cambridge, Massachusetts, US, involved fixing a spelling error involving the four base sequences — G, A, C and T — in DNA. The effect was to change an incorrect DNA letter to the right one Gina Kolata Published 07.04.25, 10:24 AM Researchers have corrected a disease-causing gene mutation with a single infusion carrying a treatment that precisely targeted the errant gene.